Tekla Capital Management logo

Tekla Capital Management

North America, Massachusetts, United States, Boston

Description

Tekla Capital Management is an investment adviser.

Investor Profile

Tekla Capital Management has made 51 investments, with 1 in the past 12 months and 12% as lead.

Stage Focus

  • Series B (31%)
  • Series C (27%)
  • Series A (16%)
  • Post Ipo Equity (8%)
  • Series E (6%)
  • Series D (6%)
  • Series Unknown (4%)
  • Private Equity (2%)

Country Focus

  • United States (73%)
  • Switzerland (8%)
  • Iceland (6%)
  • France (4%)
  • Canada (4%)
  • The Netherlands (2%)
  • United Kingdom (2%)
  • Ireland (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Life Science
  • Oncology
  • Developer Platform
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tekla Capital Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 7
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 7
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 7
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
CA
North America, Massachusetts, United States, Boston
Co-Investments: 6
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 5
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 7
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 5

Which angels does Tekla Capital Management often collaborate with?

TJ
North America, Massachusetts, United States, Cambridge
Shared Deals: 2
JR
North America, California, United States, San Francisco
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Tekla Capital Management?

Endeavor BioMedicines

Solana Beach, California, United States

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

BiotechnologyHealth CareMedical
Series CApr 24, 2024
Amount Raised: $132,500,000
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityMar 3, 2023
Amount Raised: $91,000,000
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series CJan 6, 2023
Amount Raised: $138,629,699
Invetx

Boston, Massachusetts, United States

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

BiopharmaBiotechnologyVeterinary
Series BMay 10, 2022
Amount Raised: $60,500,000
MoonLake Immunotherapeutics

Zug, Zug, Switzerland

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Biotechnology
Post Ipo EquityApr 6, 2022
Amount Raised: $115,000,000
Arkuda Therapeutics

Cambridge, Massachusetts, United States

Arkuda Therapeutics is a pharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BFeb 10, 2022
Amount Raised: $64,000,000
Endeavor BioMedicines

Solana Beach, California, United States

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

BiotechnologyHealth CareMedical
Series BFeb 7, 2022
Amount Raised: $101,000,000
Quell Therapeutics

London, England, United Kingdom

Quell Therapeutics is a cell therapy company

AssociationBiotechnologyEducationHealth Care
Series BNov 29, 2021
Amount Raised: $156,000,000
Arbor Biotechnologies

Cambridge, Massachusetts, United States

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.

BiopharmaBiotechnologyLife Science
Series BNov 9, 2021
Amount Raised: $215,000,000
Parthenon Therapeutics

Cambridge, Massachusetts, United States

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

BiotechnologyLife ScienceTherapeutics
Series ANov 3, 2021
Amount Raised: $65,000,000